Moody Lynn & Lieberson, LLC Amgen Inc Transaction History

Moody Lynn & Lieberson, LLC

$1.47 Billion
Q2 2024

A detailed history of Moody Lynn & Lieberson, LLC transactions in Amgen Inc stock. As of the latest transaction made, Moody Lynn & Lieberson, LLC holds 13,912 shares of AMGN stock, worth $4.63 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

13,912

Previous 2,842 389.51%

Holding current value

$4.63 Million

Previous $808,000 437.87%

% of portfolio

0.29%

Previous 0.06%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	BUY	$262.75 - $319.31 $2.91 Million - $3.53 Million	11,070 Added 389.51%	13,912 $4.35 Million
Q3 2023 Oct 24, 2023	SELL	$218.65 - $271.46 $23,395 - $29,046	-107 Reduced 3.63%	2,842 $763,000
Q2 2023 Jul 27, 2023	BUY	$214.27 - $253.37 $272,122 - $321,779	1,270 Added 75.64%	2,949 $654,000
Q1 2023 May 02, 2023	SELL	$225.79 - $275.2 $2.64 Million - $3.21 Million	-11,675 Reduced 87.43%	1,679 $405,000
Q4 2022 Feb 01, 2023	BUY	$229.03 - $291.01 $2.67 Million - $3.4 Million	11,675 Added 695.35%	13,354 $3.51 Million
Q2 2022 Jul 28, 2022	BUY	$230.71 - $256.74 $44,988 - $50,064	195 Added 13.14%	1,679 $409,000
Q3 2021 Oct 26, 2021	SELL	$212.27 - $248.7 $4,245 - $4,974	-20 Reduced 1.33%	1,484 $316,000
Q2 2021 Jul 28, 2021	SELL	$233.58 - $259.14 $14,248 - $15,807	-61 Reduced 3.9%	1,504 $367,000
Q1 2021 Apr 23, 2021	BUY	$221.91 - $258.6 $8,876 - $10,344	40 Added 2.62%	1,565 $389,000
Q1 2020 Apr 30, 2020	SELL	$182.24 - $241.7 $3.93 Million - $5.21 Million	-21,574 Reduced 93.4%	1,525 $309,000
Q4 2019 Jan 28, 2020	BUY	$189.21 - $243.2 $4.37 Million - $5.62 Million	23,099 New	23,099 $5.57 Million
Q1 2019 Apr 23, 2019	SELL	$180.87 - $203.88 $8.04 Million - $9.07 Million	-44,467 Closed	0 $0
Q4 2018 Jan 29, 2019	BUY	$178.4 - $208.25 $3.7 Million - $4.32 Million	20,767 Added 87.62%	44,467 $8.66 Million
Q3 2018 Oct 29, 2018	BUY	$185.29 - $208.89 $3.64 Million - $4.11 Million	19,665 Added 487.36%	23,700 $4.91 Million
Q2 2018 Jul 24, 2018	BUY	$166.05 - $186.51 $670,011 - $752,567	4,035 New	4,035 $745,000
Q4 2017 Feb 02, 2018	SELL	$168.79 - $188.59 $2.13 Million - $2.38 Million	-12,620 Closed	0 $0
Q3 2017 Nov 06, 2017	BUY	$167.29 - $191.0 $2.11 Million - $2.41 Million	12,620	12,620 $2.35 Million

Others Institutions Holding AMGN

# of Institutions

3,054

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $178B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Moody Lynn & Lieberson, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moody Lynn & Lieberson, LLC with notifications on news.

Account

Moody Lynn & Lieberson, LLC Amgen Inc Transaction History